Virax Biolabs (NASDAQ: VRAX) has signed a multi-country commercial supply agreement with Fosun Diagnostics, a subsidiary of Fosun Pharma, to expand the distribution of its diagnostic products across international markets. Sector: Biotechnology / Diagnostics Key Highlights: 🤝 Signed a multi-country commercial supply agreement with Fosun Diagnostics 🌍 Expands the international distribution of Virax's diagnostic products 🏥 Fosun Diagnostics is a subsidiary of Fosun Pharma 📈 Strengthens Virax's commercial presence across multiple global markets 💼 Supports the company's long-term commercialization and revenue growth strategy Why It Matters: The agreement expands Virax Biolabs' global commercial footprint by leveraging Fosun Diagnostics' distribution network, providing broader market access for its diagnostic portfolio. https://www.thinksabio.com.reports/isr/VRAX